As of 2025-05-17, the EV/EBITDA ratio of Arcus Biosciences Inc (RCUS) is -2.65. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Arcus's latest enterprise value is 804.42 mil USD. Arcus's TTM EBITDA according to its financial statements is -304.00 mil USD. Dividing these 2 quantities gives us the above Arcus EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 13.3x | 13.2x |
| Forward P/E multiples | 16.6x - 30.9x | 19.0x |
| Fair Price | (46.58) - (37.28) | (45.26) |
| Upside | -644.1% - -535.5% | -628.7% |
| Date | EV/EBITDA |